Publications

Publications pour l'équipe Oncostat

Titre Publication Type Publication year Auteur
Enjeux méthodologiques de la médecine de précision en oncologie journalArticle 2017 Asselain, B.; Paoletti, X.
French Health Technology Assessment Of Antineoplastic Drugs Indicated In The Treatment Of Solid Tumours: Perspective For Future Trends journalArticle 2015 Chouaid, C.; Borget, I.; Braun, E.; Bazil, M.; Schaetz, D.; Rémuzat, C.; Toumi, M.
Patients' perceived tolerance of side effects in phase I cancer clinical trials: A qualitative study journalArticle 2017 Bredart, A.; Bodson, S.; Le Tourneau, C.; Flahault, C.; Bonnetain, F.; Beaudeau, A.; Coquan, E.; Dolbeault, S.; Paoletti, X.
A joint model for the dependence between clustered times to tumour progression and deaths: A meta-analysis of chemotherapy in head and neck cancer journalArticle 2015 Rondeau, V.; Pignon, J. P.; Michiels, S.; Group, Mach-Nc collaborative
Survival after complete cytoreductive surgery and HIPEC for extensive pseudomyxoma peritonei journalArticle 2019 Benhaim, L.; Faron, M.; Gelli, M.; Sourrouille, I.; Honore, C.; Delhorme, J. B.; Elias, D.; Goere, D.
Reply to V.P. Retel et al, D. Gauchan et al, and C. Rahilly-Tierney et al journalArticle 2015 Bonastre, J.; Marguet, S.; Lueza, B.; Michiels, S.; Delaloge, S.; Saghatchian, M.
Effects of Estrogen Receptor and Human Epidermal Growth Factor Receptor-2 Levels on the Efficacy of Trastuzumab: A Secondary Analysis of the HERA Trial journalArticle 2016 Loi, S.; Dafni, U.; Karlis, D.; Polydoropoulou, V.; Young, B. M.; Willis, S.; Long, B.; de Azambuja, E.; Sotiriou, C.; Viale, G.; Ruschoff, J.; Piccart, M. J.; Dowsett, M.; Michiels, S.; Leyland-Jones, B.
Designs of drug-combination phase I trials in oncology: a systematic review of the literature journalArticle 2015 Riviere, M. K.; Le Tourneau, C.; Paoletti, X.; Dubois, F.; Zohar, S.
Reply to V.P. Retel et al, D. Gauchan et al, and C. Rahilly-Tierney et al journalArticle 2015 Bonastre, J.; Marguet, S.; Lueza, B.; Michiels, S.; Delaloge, S.; Saghatchian, M.
Concurrent chemoradiotherapy with cisplatin or cetuximab for locally advanced head and neck squamous cell carcinomas: Does human papilloma virus play a role? journalArticle 2016 Ou, D.; Levy, A.; Blanchard, P.; Nguyen, F.; Garberis, I.; Casiraghi, O.; Scoazec, J. Y.; Janot, F.; Temam, S.; Deutsch, E.; Tao, Y.
Assessing head and neck cancer patient preferences and expectations: A systematic review journalArticle 2016 Blanchard, P.; Volk, R. J.; Ringash, J.; Peterson, S. K.; Hutcheson, K. A.; Frank, S. J.
Trends in Management of Oligometastatic Hormone-Sensitive Prostate Cancer journalArticle 2019 Kothari, G.; Ost, P.; Cheung, P.; Blanchard, P.; Tree, A. C.; van As, N. J.; Lo, S. S.; Moghanaki, D.; Loblaw, A.; Siva, S.
Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973) journalArticle 2018 Goéré, D.; Pignon, J. P.; Gelli, M.; Elias, D.; Benhaim, L.; Deschamps, F.; Caramella, C.; Boige, V.; Ducreux, M.; de Baere, T.; Malka, D.
Influence of the vocal cord mobility in salvage surgery after radiotherapy for early-stage squamous cell carcinoma of the glottic larynx journalArticle 2015 Gorphe, P.; Blanchard, P.; Temam, S.; Janot, F.
Mutation-Independent Activation of the Anaplastic Lymphoma Kinase in Neuroblastoma journalArticle 2016 Regairaz, M.; Munier, F.; Sartelet, H.; Castaing, M.; Marty, V.; Renauleaud, C.; Doux, C.; Delbe, J.; Courty, J.; Fabre, M.; Ohta, S.; Vielh, P.; Michiels, S.; Valteau-Couanet, D.; Vassal, G.
Looking Beyond the Numbers: Highlighting the Challenges of Population-Based Studies in Cancer Research journalArticle 2016 Blanchard, P.; Garden, A. S.
Inflammatory bowel diseases activity in patients undergoing pelvic radiation therapy journalArticle 2017 Annede, P.; Seisen, T.; Klotz, C.; Mazeron, R.; Maroun, P.; Petit, C.; Deutsch, E.; Bossi, A.; Haie-Meder, C.; Chargari, C.; Blanchard, P.
Busulfan-Melphalan followed by autologous stem cell transplantation in patients with high-risk neuroblastoma or Ewing sarcoma: an exposed-unexposed study evaluating the clinical impact of the order of drug administration journalArticle 2016 Dourthe, M. E.; Ternes, N.; Gajda, D.; Paci, A.; Dufour, C.; Benhamou, E.; Valteau-Couanet, D.
Prognostic and predictive factors for angiosarcoma patients receiving paclitaxel once weekly plus or minus bevacizumab: an ancillary study derived from a randomized clinical trial journalArticle 2018 Lebellec, L.; Bertucci, F.; Tresch-Bruneel, E.; Ray-Coquard, I.; Le Cesne, A.; Bompas, E.; Blay, J. Y.; Italiano, A.; Mir, O.; Ryckewaert, T.; Toiron, Y.; Camoin, L.; Goncalves, A.; Penel, N.; Le Deley, M. C.
Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study journalArticle 2015 Libé, R.; Borget, I.; Ronchi, C. L.; Zaggia, B.; Kroiss, M.; Kerkhofs, T.; Bertherat, J.; Volante, M.; Quinkler, M.; Chabre, O.; Bala, M.; Tabarin, A.; Beuschlein, F.; Vezzosi, D.; Deutschbein, T.; Borson-Chazot, F.; Hermsen, I.; Stell, A.; Fottner, C.; Leboulleux, S.; Hahner, S.; Mannelli, M.; Berruti, A.; Haak, H.; Terzolo, M.; Fassnacht, M.; Baudin, E.
Diagnosis of systemic inflammatory diseases among patients admitted for acute pericarditis with pericardial effusion journalArticle 2017 Assayag, M.; Abbas, R.; Chanson, N.; Perozziello, A.; Ducrocq, G.; Alexandra, J. F.; Dossier, A.; Papo, T.; Sacre, K.
Innovations for phase I dose-finding designs in pediatric oncology clinical trials journalArticle 2016 Doussau, A.; Geoerger, B.; Jimenez, I.; Paoletti, X.
Quality of Life and Cost-Effectiveness Assessment of Radioiodine Ablation Strategies in Patients With Thyroid Cancer: Results From the Randomized Phase III ESTIMABL Trial journalArticle 2015 Borget, I.; Bonastre, J.; Catargi, B.; Déandréis, D.; Zerdoud, S.; Rusu, D.; Bardet, S.; Leenhardt, L.; Bastie, D.; Schvartz, C.; Vera, P.; Morel, O.; Benisvy, D.; Bournaud, C.; Bonichon, F.; Kelly, A.; Toubert, M. E.; Leboulleux, S.; Journeau, F.; Benhamou, E.; Schlumberger, M.
Bayesian survival analysis in clinical trials: What methods are used in practice? journalArticle 2017 Brard, C.; Le Teuff, G.; Le Deley, M. C.; Hampson, L. V.
Impact of time to local recurrence on the occurrence of metastasis in breast cancer patients treated with neoadjuvant chemotherapy: A random forest survival approach journalArticle 2019 Laas, E.; Hamy, A. S.; Michel, A. S.; Panchbhaya, N.; Faron, M.; Lam, T.; Carrez, S.; Pierga, J. Y.; Rouzier, R.; Lerebours, F.; Feron, J. G.; Reyal, F.
Circulating Cell-Free Tumor DNA Analysis of 50 Genes by Next-Generation Sequencing in the Prospective MOSCATO Trial journalArticle 2016 Jovelet, C.; Ileana, E.; Le Deley, M. C.; Motte, N.; Rosellini, S.; Romero, A.; Lefebvre, C.; Pedrero, M.; Pata-Merci, N.; Droin, N.; Deloger, M.; Massard, C.; Hollebecque, A.; Ferte, C.; Boichard, A.; Postel-Vinay, S.; Ngo-Camus, M.; De Baere, T.; Vielh, P.; Scoazec, J. Y.; Vassal, G.; Eggermont, A.; Andre, F.; Soria, J. C.; Lacroix, L.
Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: a dose-finding phase 1 trial journalArticle 2018 Pannier, D.; Adenis, A.; Bogart, E.; Dansin, E.; Clisant-Delaine, S.; Decoupigny, E.; Lesoin, A.; Amela, E.; Ducornet, S.; Meurant, J. P.; Le Deley, M. C.; Penel, N.
Value of a short-term imaging follow-up after a benign result in a one-stop breast unit: Is it still useful? journalArticle 2017 Daroles, J.; Borget, I.; Suciu, V.; Mazouni, C.; Delaloge, S.; Balleyguier, C.
Post-first-line FOLFOX chemotherapy for grade 3 neuroendocrine carcinoma journalArticle 2015 Hadoux, J.; Malka, D.; Planchard, D.; Scoazec, J. Y.; Caramella, C.; Guigay, J.; Boige, V.; Leboulleux, S.; Burtin, P.; Berdelou, A.; Loriot, Y.; Duvillard, P.; Chougnet, C. N.; Déandréis, D.; Schlumberger, M.; Borget, I.; Ducreux, M.; Baudin, E.
Phase I trial of bortezomib daily dose: safety, pharmacokinetic profile, biological effects and early clinical evaluation in patients with advanced solid tumors journalArticle 2018 Bahleda, R.; Le Deley, M. C.; Bernard, A.; Chaturvedi, S.; Hanley, M.; Poterie, A.; Gazzah, A.; Varga, A.; Touat, M.; Deutsch, E.; Massard, C.; Van De Velde, H.; Hollebecque, A.; Sallansonnet-Froment, M.; Ricard, D.; Taillia, H.; Angevin, E.; Ribrag, V.; Soria, J. C.
[Individualization of dose and fractionation of radiotherapy for head and neck cancers] journalArticle 2019 Blanchard, P.; Biau, J.; Castelli, J.; Tao, Y.; Graff, P.; Nguyen, F.
Improved Treatment of Breast Cancer with Anti-HER2 Therapy Requires Interleukin-21 Signaling in CD8+ T Cells journalArticle 2016 Mittal, D.; Caramia, F.; Michiels, S.; Joensuu, H.; Kellokumpu-Lehtinen, P. L.; Sotiriou, C.; Loi, S.; Smyth, M. J.
Impact of prophylactic central neck dissection on oncologic outcomes of papillary thyroid carcinoma: a review journalArticle 2015 Mamelle, E.; Borget, I.; Leboulleux, S.; Mirghani, H.; Suárez, C.; Pellitteri, P. K.; Shaha, A. R.; Hamoir, M.; Robbins, K. T.; Khafif, A.; Rodrigo, J. P.; Silver, C. E.; Rinaldo, A.; Ferlito, A.; Hartl, D. M.
Evaluation of Treatment Effect with Paired Failure Times in a Single-Arm Phase II Trial in Oncology journalArticle 2018 Texier, M.; Rotolo, F.; Ducreux, M.; Bouché, O.; Pignon, J. P.; Michiels, S.
LONG-TERM SURVIVAL IN PATIENTS RESPONDING TO ANTI-PD-1/PD-L1 THERAPY AND DISEASE OUTCOME UPON TREATMENT DISCONTINUATION journalArticle 2018 Gauci, M. L.; Lanoy, E.; Champiat, S.; Caramella, C.; Ammari, S.; Aspeslagh, S.; Varga, A.; Baldini, C.; Bahleda, R.; Gazzah, A.; Michot, J. M.; Postel-Vinay, S.; Angevin, E.; Ribrag, V.; Hollebecque, A.; Soria, J. C.; Robert, C.; Massard, C.; Marabelle, A.
Somatic mutation, copy number and transcriptomic profiles of primary and matched metastatic estrogen receptor-positive breast cancers journalArticle 2016 Fumagalli, D.; Wilson, T. R.; Salgado, R.; Lu, X.; Yu, J.; O'Brien, C.; Walter, K.; Huw, L. Y.; Criscitiello, C.; Laios, I.; Jose, V.; Brown, D. N.; Rothe, F.; Maetens, M.; Zardavas, D.; Savas, P.; Larsimont, D.; Piccart-Gebhart, M. J.; Michiels, S.; Lackner, M. R.; Sotiriou, C.; Loi, S.
INTRODUCTION OF INNOVATIVE MEDICAL DEVICES AT FRENCH UNIVERSITY HOSPITALS: AN OVERVIEW OF HOSPITAL-BASED HEALTH TECHNOLOGY ASSESSMENT INITIATIVES journalArticle 2015 Martelli, N.; Billaux, M.; Borget, I.; Pineau, J.; Prognon, P.; van den Brink, H.
Safety and efficacy of anti-programmed death 1 antibodies in patients with cancer and pre-existing autoimmune or inflammatory disease journalArticle 2018 Danlos, F. X.; Voisin, A. L.; Dyevre, V.; Michot, J. M.; Routier, E.; Taillade, L.; Champiat, S.; Aspeslagh, S.; Haroche, J.; Albiges, L.; Massard, C.; Girard, N.; Dalle, S.; Besse, B.; Laghouati, S.; Soria, J. C.; Mateus, C.; Robert, C.; Lanoy, E.; Marabelle, A.; Lambotte, O.
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials) journalArticle 2015 Gourgou-Bourgade, S.; Cameron, D.; Poortmans, P.; Asselain, B.; Azria, D.; Cardoso, F.; A'Hern, R.; Bliss, J.; Bogaerts, J.; Bonnefoi, H.; Brain, E.; Cardoso, M. J.; Chibaudel, B.; Coleman, R.; Cufer, T.; Dal Lago, L.; Dalenc, F.; De Azambuja, E.; Debled, M.; Delaloge, S.; Filleron, T.; Gligorov, J.; Gutowski, M.; Jacot, W.; Kirkove, C.; MacGrogan, G.; Michiels, S.; Negreiros, I.; Offersen, B. V.; Penault Llorca, F.; Pruneri, G.; Roche, H.; Russell, N. S.; Schmitt, F.; Servent, V.; Thürlimann, B.; Untch, M.; van der Hage, J. A.; van Tienhoven, G.; Wildiers, H.; Yarnold, J.; Bonnetain, F.; Mathoulin-Pélissier, S.; Bellera, C.; Dabakuyo-Yonli, T. S.
Optimizing Local Control in High-Grade Uterine Sarcoma: Adjuvant Vaginal Vault Brachytherapy as Part of a Multimodal Treatment journalArticle 2017 Annede, P.; Gouy, S.; Mazeron, R.; Bentivegna, E.; Maroun, P.; Petit, C.; Dumas, I.; Leary, A.; Genestie, C.; Lhomme, C.; Deutsch, E.; Morice, P.; Pautier, P.; Haie-Meder, C.; Chargari, C.